Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication indicated for attention deficit hyperactivity disorder in youngsters and adults . In Canada, its distribution is managed by Health Canada. https://orderlisdexamfetamineinc040972.tribunablog.com/lisdexamfetamine-in-canada-a-detailed-guide-57935400